Journals / Bakırköy Tıp Dergisi / 2011 / Cilt: 7 - Sayı: 2

Urine macrophage migration inhibitory factor levels in children with renal scarring due to recurrent urinary tract infections

Tekrarlayan üriner sistem enfeksiyonlarına bağlı oluşan renal skarda idrar makrofaj migrasyon inhibitör faktör düzeylerinin değerlendirilmesi

Pages
52–55
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In patient with renal scarring, for using urine MIF levels as a biochemical marker, more prospective studies are needed on this subject

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that plays an important role in several disease including sepsis, pneumonia, diabetes, rheumatoid arthritis, inflammatory bowel disease and cancer.
📊
Key Findings & Data:Dimercaptosuccinic acid (DMSA) scintigraphy revealed renal scarring in 44 of them.
💡
Conclusion & Impact:Conclusion: In patient with renal scarring, for using urine MIF levels as a biochemical marker, more prospective studies are needed on this subject
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that plays an important role in several disease including sepsis, pneumonia, diabetes, rheumatoid arthritis, inflammatory bowel disease and cancer. In this study, our aim was to examine the levels of macrophage migration inhibitory factor in children with renal scarring due to recurrent urinary tract infection Material and methods: Eighty eight children with renal scarring due to recurrent urinary tract infection were included. Dimercaptosuccinic acid (DMSA) scintigraphy revealed renal scarring in 44 of them. Macrophage migration inhibitory factor were analyzed by ELISA from the urine samples in both groups. Results: Urine MIF levels were statistically significantly high in renal scar group than without scar group (p<0.001), the average levels of urine MIF in scar group was 331,14 ± 256,20 (254,85) than those in patients without scar 195,30±298,68 (111,55) MIF/creatinine levels were not statistically significant between groups (p>0.05). Conclusion: In patient with renal scarring, for using urine MIF levels as a biochemical marker, more prospective studies are needed on this subject

Özet

Amaç: Makrofaj migrasyon inhibitör faktör (MIF) sepsis, pnömoni, diyabet, romatoid artrit, inşamatuvar barsak hastalığı ve kanser gibi birçok hastalıkta etken rol oynayan pleiotropik proinşamatuvar bir sitokindir. Bu çalışmada tekrarlayan üriner sistem enfeksiyonuna bağlı gelişen renal skarda makrofaj migrasyon inhibitör faktör düzeylerinin incelenmesi amaçlandı. Gereç ve yöntem: Çalışmaya tekrarlayan üriner sistem enfeksiyonu nedeniyle takip edilen 88 çocuk hasta dahil edildi. Çocukların 44 tanesinde sintigrafi ile doğrulanan renal skar vardı. Her iki gruptan alınan idrar örneklerinde makrofaj migrasyon inhibitör faktör ELISA yöntemi ile analiz edildi. Bulgular: Renal skar olmayan grup ile skarlı grup MIF düzeyleri arasında istatistiksel olarak ileri düzeyde anlamlı farklılık bulunmuştur (p 0,05). Sonuç: Renal skar varlığında idrar MIF düzeylerinin, biyokimyasal bir belirteç olarak kullanılabilmesi için bu konuda daha çok prospektif çalışmaya ihtiyaç vardır.

🔖

Cite This Article

GEDİKBAŞI, A., HATİPOĞLU, S., YILMAZ, A., ŞEVKETOĞLU, E., KARYAĞAR, S., KIYAK, A., MÜLAZIMOĞLU, M., AYDOĞAN, G., ÖZPAÇACI, T. (2011). Urine macrophage migration inhibitory factor levels in children with renal scarring due to recurrent urinary tract infections. Bakırköy Tıp Dergisi, Cilt: 7 - Sayı: 2, 52–55. https://ajindex.com/articles/129421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Medical versus surgical treatment of primary vesicoureteral reflux: Report of the International Reflux Study Committee. Pediatrics 1981; 67: 392-400
  2. Rushton HG, Jodal U. Vesicoureteral reflux and renal scarring. In: Avner ED, Harmon WEB, Niaudet P (Eds). Pediatric Nephrology, 5th edition, Philadelphia, USA, Lippincott Williams&Wilkins, 2004: pp.1027-1048
  3. Bhatnagar V, Mitra DK, Agarwala S, et al. The role of DMSA scans in evaluation of the correlation between urinary tract infection, vesicoureteric reflux, and renal scarring. Pediatr Surg Int 2002; 18: 128-134
  4. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800
  5. Chagnon F, Metz CN, Bucala R, Lesur O. Endotoxin-induced myocardial dysfunction effects of macrophage migration inhibitory factor neutralization. Circ Res 2005; 96: 1095-1102
  6. Meyer-Siegler KL, Leifheit EC, Vera PL. Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 2004; 4: 34
  7. Meyer-Siegler KL, Vera PL. Substance P induced release of macrophage migration inhibitory factor from rat bladder epithelium. J Urol 2004; 171: 1698-1703
  8. Meyer-Siegler KL, Vera PL. Intraluminal antibodies to macrophage migration inhibitory factor decrease substance P induced inflammatory changes in the rat bladder and prostate. J Urol, 2004; 172: 1504-1509
  9. Mir S, Aydınok Y, Kabasakal C, Aksu N, Cura A. Veziko üreteral reflü olgularında renal skarın değerlendirilmesinde Beta-2 mikroglobulin. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 1992; 2: 112-116
  10. Goldraich NP, Ramos OL, Goldraich IH. Urography versus DMSA scan in children with vesicoureteric reflux. Pediatr Nephrol 1989; 3:1-5
  11. Lan HY, Mu W, Yang N, et al. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996; 149: 1119- 1127
  12. Lan HY, Yang N, Brown FG, et al. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998; 66: 1465-1471
  13. Lan HY, Yang N, Nikolic-Paterson DJ, et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57: 499-509
  14. Tang S, Leung JC, Tsang AW, et al. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: Implication on mechanism of tubuloglomerular communication in g